XKRX:330350 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
6660.00
(-1.19%)
Nov 29
Business Description
Withus Pharmaceutical Co Ltd
ISIN : KR7330350000
Share Class Description:
XKRX:330350: Ordinary SharesCompare
Compare
Traded in other countries / regions
330350.Korea IPO Date
2020-07-03Description
Withus Pharmaceutical Co Ltd is a pharmaceutical company. The firm is engaged in the manufacturing and selling of various medicines such as Broazette long-acting tablet, Wipina tablets, Mantini tablets, and Choline syrup among others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.59 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | 1.71 | |||||
| Interest Coverage | 10.36 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.44 | |||||
| Beneish M-Score | -2.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.5 | |||||
| 3-Year EBITDA Growth Rate | -2.1 | |||||
| 3-Year EPS without NRI Growth Rate | -8.9 | |||||
| 3-Year Book Growth Rate | 5.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.4 | |||||
| 9-Day RSI | 45.57 | |||||
| 14-Day RSI | 44.22 | |||||
| 6-1 Month Momentum % | -8.88 | |||||
| 12-1 Month Momentum % | -34.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.84 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 0.38 | |||||
| Days Inventory | 147.31 | |||||
| Days Sales Outstanding | 86.5 | |||||
| Days Payable | 47.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.5 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| 3-Year Dividend Growth Rate | -9.9 | |||||
| Forward Dividend Yield % | 1.5 | |||||
| 5-Year Yield-on-Cost % | 1.5 | |||||
| Shareholder Yield % | 1.02 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.74 | |||||
| Operating Margin % | 7.87 | |||||
| Net Margin % | 6.36 | |||||
| FCF Margin % | -4.56 | |||||
| ROE % | 7.43 | |||||
| ROA % | 5.19 | |||||
| ROIC % | 7.12 | |||||
| ROC (Joel Greenblatt) % | 10.83 | |||||
| ROCE % | 8.25 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.08 | |||||
| PE Ratio without NRI | 12.26 | |||||
| PS Ratio | 0.82 | |||||
| PB Ratio | 0.95 | |||||
| Price-to-Tangible-Book | 1.08 | |||||
| Price-to-Operating-Cash-Flow | 23.37 | |||||
| EV-to-EBIT | 11.8 | |||||
| EV-to-EBITDA | 8.15 | |||||
| EV-to-Revenue | 0.9 | |||||
| EV-to-FCF | -20.19 | |||||
| Price-to-Graham-Number | 0.77 | |||||
| Price-to-Net-Current-Asset-Value | 4.67 | |||||
| Earnings Yield (Greenblatt) % | 8.47 | |||||
| FCF Yield % | -5.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Withus Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 105,738.717 | ||
| EPS (TTM) (â‚©) | 509 | ||
| Beta | 1.02 | ||
| Volatility % | 23.4 | ||
| 14-Day RSI | 44.22 | ||
| 14-Day ATR (â‚©) | 233.696827 | ||
| 20-Day SMA (â‚©) | 6698.5 | ||
| 12-1 Month Momentum % | -34.99 | ||
| 52-Week Range (â‚©) | 6090 - 13680 | ||
| Shares Outstanding (Mil) | 13.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Withus Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Withus Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Withus Pharmaceutical Co Ltd Frequently Asked Questions
What is Withus Pharmaceutical Co Ltd(XKRX:330350)'s stock price today?
The current price of XKRX:330350 is â‚©6660.00. The 52 week high of XKRX:330350 is â‚©13680.00 and 52 week low is â‚©6090.00.
When is next earnings date of Withus Pharmaceutical Co Ltd(XKRX:330350)?
The next earnings date of Withus Pharmaceutical Co Ltd(XKRX:330350) is .
Does Withus Pharmaceutical Co Ltd(XKRX:330350) pay dividends? If so, how much?
The Dividend Yield %  of Withus Pharmaceutical Co Ltd(XKRX:330350) is 1.5% (As of Today), Highest Dividend Payout Ratio of Withus Pharmaceutical Co Ltd(XKRX:330350) was 0.2. The lowest was 0.16. And the median was 0.19. The  Forward Dividend Yield % of Withus Pharmaceutical Co Ltd(XKRX:330350) is 1.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers